GlassScriptPhysician profile
Joseph Robert Temperato
NPI 1023463700
$31,273.58
in general payments reported to CMS, 2019-2025
12 companies · $308 in 2025
The $308 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25K · 2022: $4,677 · 2023: $236 · 2024: $1,085 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,628.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $23,429.18 | 2021-2022 | |
| Medical Device Business Services, INC. | $4,968.14 | 2021 | |
| Elite Orthopedics, LLC | $1,205.35 | 2022 | |
| Stryker Corporation | $478.45 | 2022-2025 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Aequalis Flex Revive |
| Si-Bone, INC. | $308.70 | 2023-2024 | |
| Kerecis Limited | $286.15 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Depuy Synthes Sales INC. | $273.81 | 2023-2025 | Na, Fibergraft Bg Morsels, Motoband Cp |
| Cdc Medical LLC | $123.25 | 2024 | |
| Skeletal Dynamics INC | $115.15 | 2024 | Align, Implate, Ijs |
| Zimmer Biomet Holdings, INC. | $35.38 | 2024 | A.L.P.S., Affixus |
| Dynasplint Systems INC. | $33.30 | 2024 | Dynasplint |
| Coastal Medical Technologies LLC | $16.72 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Temperato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.